Daily Dose - Jan 26th, 2026
Daily Dose |
View online
January 26, 2026
Zero‑tariff deal with US positions UK for high-value pharma manufacturing
Atradius and GlobalData see Britain as having a competitive advantage in attracting pharmaceutical production, thanks to tariff exemptions for drug exports to U.S.
Read More
Recipharm builds beta-lactam tablet facility to meet FDA guidance
The investment supports compliant manufacturing of non-bacterial beta-lactam medicines amid stricter cross-contamination controls.
Read More
SpectronRx expands Indiana campus to scale radiopharma manufacturing
The Grissom Aeroplex expansion in Bunker Hill adds GMP capacity for high-volume therapeutic and diagnostic production.
Read More